NCT06875479

Brief Summary

This study will evaluate and compare the diagnostic accuracy and effectiveness of the Five Seasons Sleep Tracking Mat with the gold standard, polysomnography.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 13, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

March 9, 2025

Last Update Submit

April 15, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Diagnostic sensitivity (AHI = 5) of 5S Sleep Tracking Mat compared to PSG

    The proportion of participants with Apnea Hypopnea Index (AHI) ≥ 5 events per hour according to 5S Sleep Tracking Mat in participants with AHI ≥ 5 events per hour according to PSG scored with American Academy of Sleep Medicine (AASM) v2.6 Guidelines. The point estimation of diagnostic sensitivity of 5S Sleep Tracking Mat will be compared to the threshold of 0.8, with the half width of 95% confidence interval being no more than 0.1.

    Day 1

  • Diagnostic specificity (AHI = 5) of 5S Sleep Tracking Mat compared to PSG

    The proportion of participants with Apnea Hypopnea Index (AHI) ≥ 5 events per hour according to 5S Sleep Tracking Mat in participants with AHI ≥ 5 events per hour according to PSG scored with American Academy of Sleep Medicine (AASM) v2.6 Guidelines. The point estimation of diagnostic specificity of 5S Sleep Tracking Mat will be compared to the threshold of 0.8, with the half width of 95% confidence interval being no more than 0.1.

    Day 1

Secondary Outcomes (26)

  • Diagnostic sensitivity (AHI = 15) of 5S Sleep Tracking Mat compared to PSG

    Day 1

  • Diagnostic specificity (AHI = 30) of 5S Sleep Tracking Mat compared to PSG

    Day 1

  • Diagnostic sensitivity (AHI = 30) of 5S Sleep Tracking Mat compared to PSG

    Day 1

  • Overall accuracy of 5S Sleep Tracking Mat at AHI = 5

    Day 1

  • Overall accuracy of 5S Sleep Tracking Mat at AHI = 15

    Day 1

  • +21 more secondary outcomes

Interventions

The Five Seasons \[5S\] Sleep Tracking Mat consists of a main control box, monitoring mat, temperature/humidity sensor, power adapter, and light sensor. It utilizes Ballistocardiogram (BCG) technology to detect heartbeat, respiration, body movements, and snoring. The collected data is analyzed by a proprietary pre-trained AI model, enabling automatic detection of respiratory events, calculation of the Apnea-Hypopnea Index (AHI), and sleep stage interpretation. Compared to other sleep monitoring devices, it is non-contact and requires no wearable components, making it particularly suitable for long-term, daily home use.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Age between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA, recruited by department of otorhinolaryncology in collaborative hospitals.

You may qualify if:

  • Participants between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA.
  • Participants who are willing to undergo overnight PSG.

You may not qualify if:

  • Participants with presence of severe cardiovascular or cerebrovascular diseases, or significant impairment of liver, kidney, or lung function.
  • Participants with concurrent unstable respiratory diseases or other acute-phase respiratory illnesses.
  • Participants using, at long term or currently, barbiturates, benzodiazepines, sedatives, or other medications that may affect sleep.
  • Participants undergoing continuous positive airway pressure (CPAP) therapy or other sleep-related treatments on the study night.
  • Participants coexisting insomnia, parasomnia, or other sleep disorders.
  • Participants with psychiatric disorders.
  • Participants refusing to sign the informed consent form.
  • Participants unable to cooperate with the required examinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, 200025, China

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Weijun Huang, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

March 9, 2025

First Posted

March 13, 2025

Study Start

April 20, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be shared.

Locations